The Editors have satisfied themselves that all authors have contributed significantly to this publication
Detection of disseminated tumour cells in blood and bone marrow samples of patients undergoing hepatic resection for metastasis of colorectal cancer†
Article first published online: 15 MAY 2003
Copyright © 2003 British Journal of Surgery Society Ltd. Published by John Wiley & Sons, Ltd.
British Journal of Surgery
Volume 90, Issue 8, pages 989–995, August 2003
How to Cite
Vlems, F. A., Diepstra, J. H. S., Punt, C. J. A., Ligtenberg, M. J. L., Cornelissen, I. M. H. A., van Krieken, J. H. J. M., Wobbes, T., van Muijen, G. N. P. and Ruers, T. J. M. (2003), Detection of disseminated tumour cells in blood and bone marrow samples of patients undergoing hepatic resection for metastasis of colorectal cancer. Br J Surg, 90: 989–995. doi: 10.1002/bjs.4161
- Issue published online: 30 JUL 2003
- Article first published online: 15 MAY 2003
- Manuscript Accepted: 25 JAN 2003
In 50–60 per cent of patients who undergo hepatic resection for metastasis of colorectal cancer the first site of tumour recurrence is extrahepatic, indicating the presence of more extensive disease at the time of resection. The aim of this study was to evaluate whether the presence of disseminated tumour cells in blood and bone marrow could predict extrahepatic tumour recurrence.
Cytokeratin 20 (CK20) reverse transcriptase–polymerase chain reaction was used to study the presence of tumour cells in preoperative peripheral blood and bone marrow samples from 41 patients with liver metastasis scheduled for surgical resection.
CK20 expression was detected in six of 41 peripheral blood samples and in eight of 32 bone marrow samples. There was no correlation between CK20-positive samples and subsequent extrahepatic recurrence. Positive blood samples did, however, correlate with high serum carcinoembryonic antigen level and large tumour volume. None of the 14 patients previously treated with chemotherapy had CK20-positive samples, whereas six of 27 blood and eight of 20 bone marrow samples were positive in the chemotherapy-naive group.
Although the number of patients in this study is limited, the presence of disseminated tumour cells did not predict subsequent extrahepatic recurrence. The results strongly suggest that the presence of circulating tumour cells in peripheral blood may reflect transient shedding of tumour cells related to large tumour volume. Copyright © 2003 British Journal of Surgery Society Ltd. Published by John Wiley & Sons, Ltd.